| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Hepatitis B Surface Antibody
MessagePerformed in the Chemistry Laboratory x5820.
10.2018
10.2018
Test Code
HBSAB
Alias/See Also
AUSAB
CPT Codes
86706
Preferred Specimen
Plasma from a green top (PST) tube
Minimum Volume
1 mL
Transport Container
Green Top (PST) tube
Transport Temperature
Room temperature
Specimen Stability
2 - 8 oC: 7 days
Methodology
Chemiluminescent Microparticle Immunoassay
Setup Schedule
This assay is performed Monday through Friday
Reference Range
NON-REACTIVE: < 8.0 mIU/mL
EQUIVOCAL: ≥ 8.0 to < 12.0 mIU/mL
REACTIVE: ≥ 12.0 Miu/mL
Note:
A non-reactive test result does not exclude the possibility of exposure to HBV.
Assay does not distinquish between vaccination and viral exposure
EQUIVOCAL: ≥ 8.0 to < 12.0 mIU/mL
REACTIVE: ≥ 12.0 Miu/mL
Note:
A non-reactive test result does not exclude the possibility of exposure to HBV.
Assay does not distinquish between vaccination and viral exposure
Clinical Significance
Antibodies against hepatitis B virus surface antigen (Anti-HBs) are a marker of immunity against hepatitis B virus infection, although depending on an appropriately high titer/concentration. An additional test for antibodies against the hepatitis B virus core antigen (total Anti-HBc (HBCOR)) can help to interpret clinical situations in which Anti-HBs are reactive. Anti-HBs appear one to three months after vaccination (total Anti-HBc (HBCOR) non-reactive) or after recovery from acute infection (total Anti-HBc (HBCOR) reactive).
Typical patterns of Hepatitis B Virus related serum markers
| Marker | No exposure * | Acute infection | Chronic infection ** | Resolved infection | Vaccination |
| HBsAg (HBSAG) | NON-REACTIVE | CONFIRMED POSITIVE | CONFIRMED POSITIVE | NON-REACTIVE | NON-REACTIVE |
| Anti-HBs (HBSAB) | NON-REACTIVE | NON-REACTIVE | NON-REACTIVE | REACTIVE | REACTIVE |
| Anti-HBc IgM (HBCM) | NON-REACTIVE | REACTIVE | NON-REACTIVE | NON-REACTIVE | NON-REACTIVE |
| total Anti-HBc (HBCOR) | NON-REACTIVE | REACTIVE | REACTIVE | REACTIVE | NON-REACTIVE |
* consider recent exposure
** in chronic Infection HBs Ag levels may wane and Anti-HBc IgM may recur in flares

